These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31605362)

  • 21. CYP21A2 mutation analysis in Korean patients with congenital adrenal hyperplasia using complementary methods: sequencing after long-range PCR and restriction fragment length polymorphism analysis with multiple ligation-dependent probe amplification assay.
    Hong G; Park HD; Choi R; Jin DK; Kim JH; Ki CS; Lee SY; Song J; Kim JW
    Ann Lab Med; 2015 Sep; 35(5):535-9. PubMed ID: 26206692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a novel compound heterozygous mutation of the CYP21A2 gene causing 21‑hydroxylase deficiency in a Chinese pedigree.
    Liu J; Zhang X; Zhang H; Fang L; Xu J; Guan Q; Xu C
    Mol Med Rep; 2018 Mar; 17(3):4265-4272. PubMed ID: 29328376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Refractory acne and 21-hydroxylase deficiency in a selected group of female patients.
    Caputo V; Fiorella S; Curiale S; Caputo A; Niceta M
    Dermatology; 2010; 220(2):121-7. PubMed ID: 20110635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism.
    Knochenhauer ES; Cortet-Rudelli C; Cunnigham RD; Conway-Myers BA; Dewailly D; Azziz R
    J Clin Endocrinol Metab; 1997 Feb; 82(2):479-85. PubMed ID: 9024240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High carrier frequency of 21-hydroxylase deficiency in Cyprus.
    Phedonos AA; Shammas C; Skordis N; Kyriakides TC; Neocleous V; Phylactou LA
    Clin Genet; 2013 Dec; 84(6):585-8. PubMed ID: 23600966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and Clinical Outcome of CYP21A2 Gene Mutations in Patients with Nonfunctional Adrenal Incidentalomas.
    Kiedrowicz B; Binczak-Kuleta A; Lubikowski J; Koziolek M; Andrysiak-Mamos E; Ostanek-Panka M; Ciechanowicz A; Syrenicz A
    Horm Metab Res; 2015 Aug; 47(9):662-7. PubMed ID: 25970792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive mutation analysis of the CYP21A2 gene: an efficient multistep approach to the molecular diagnosis of congenital adrenal hyperplasia.
    Xu Z; Chen W; Merke DP; McDonnell NB
    J Mol Diagn; 2013 Nov; 15(6):745-53. PubMed ID: 24071710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of CYP21A2 genotype and serum 17-hydroxyprogesterone and cortisol levels in a large cohort of Italian children with premature pubarche.
    Ghizzoni L; Cappa M; Vottero A; Ubertini G; Carta D; Di Iorgi N; Gasco V; Marchesi M; Raggi V; Ibba A; Napoli F; Massimi A; Maghnie M; Loche S; Porzio O
    Eur J Endocrinol; 2011 Aug; 165(2):307-14. PubMed ID: 21646284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prevalence, molecular analysis and HLA typing of late-onset 21-hydroxylase deficiency in Turkish woman with hirsutism and polycystic ovary.
    Yarman S; Dursun A; Oguz F; Alagol F
    Endocr J; 2004 Feb; 51(1):31-6. PubMed ID: 15004406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic defects of the CYP21A2 gene in girls with premature adrenarche.
    Skordis N; Shammas C; Phedonos AA; Kyriakou A; Toumba M; Neocleous V; Phylactou LA
    J Endocrinol Invest; 2015 May; 38(5):535-9. PubMed ID: 25481255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members.
    Bidet M; Bellanné-Chantelot C; Galand-Portier MB; Tardy V; Billaud L; Laborde K; Coussieu C; Morel Y; Vaury C; Golmard JL; Claustre A; Mornet E; Chakhtoura Z; Mowszowicz I; Bachelot A; Touraine P; Kuttenn F
    J Clin Endocrinol Metab; 2009 May; 94(5):1570-8. PubMed ID: 19208730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of Genotype and Hyperandrogenism on Sexual Function in Women With Congenital Adrenal Hyperplasia.
    Schernthaner-Reiter MH; Baumgartner-Parzer S; Egarter HC; Krebs M; Kautzky-Willer A; Kirchheiner K; Luger A; Bayerle-Eder M
    J Sex Med; 2019 Oct; 16(10):1529-1540. PubMed ID: 31447379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of a frequent duplicated CYP21A2 gene carrying a Q318X mutation in a general population with quantitative PCR methods.
    Kharrat M; Riahi A; Maazoul F; M'rad R; Chaabouni H
    Diagn Mol Pathol; 2011 Jun; 20(2):123-7. PubMed ID: 21532487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carriers of a Classic CYP21A2 Mutation Have Reduced Mortality: A Population-Based National Cohort Study.
    Nordenström A; Svensson J; Lajic S; Frisén L; Nordenskjöld A; Norrby C; Almqvist C; Falhammar H
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6148-6154. PubMed ID: 31393570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of CYP21A2 Genotyping Assay for the Diagnosis of Congenital Adrenal Hyperplasia.
    Prado MJ; de Castro SM; Kopacek C; de Mello MP; Rispoli T; Grandi T; da Silva CMD; Rossetti MLR
    Mol Diagn Ther; 2017 Dec; 21(6):663-675. PubMed ID: 28819757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The spectrum of CYP21A2 gene mutations in patients with classic salt wasting form of 2l-hydroxylase deficiency in a Chinese cohort.
    Liu Y; Zheng J; Liu N; Xu X; Zhang X; Zhang Y; Li G; Liu G; Cai C; Shu J
    Mol Genet Genomic Med; 2020 Nov; 8(11):e1501. PubMed ID: 32959514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiplex ligation-dependent probe amplification (MLPA) assay for the detection of CYP21A2 gene deletions/duplications in congenital adrenal hyperplasia: first technical report.
    Concolino P; Mello E; Toscano V; Ameglio F; Zuppi C; Capoluongo E
    Clin Chim Acta; 2009 Apr; 402(1-2):164-70. PubMed ID: 19263525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women.
    Blanché H; Vexiau P; Clauin S; Le Gall I; Fiet J; Mornet E; Dausset J; Bellanné-Chantelot C
    Hum Genet; 1997 Nov; 101(1):56-60. PubMed ID: 9385370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prevalence of non-classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Greek women with hirsutism and polycystic ovary syndrome.
    Trakakis E; Rizos D; Loghis C; Chryssikopoulos A; Spyropoulou M; Salamalekis E; Simeonides G; Vagopoulos V; Salamalekis G; Kassanos D
    Endocr J; 2008 Mar; 55(1):33-9. PubMed ID: 18187875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation analysis of the CYP21A2 gene in the Iranian population.
    Rabbani B; Mahdieh N; Ashtiani MT; Larijani B; Akbari MT; New M; Parsa A; Schouten JP; Rabbani A
    Genet Test Mol Biomarkers; 2012 Feb; 16(2):82-90. PubMed ID: 22017335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.